Most cognitive protocols underperform because they address only half of the system. You can optimize daytime focus all you want, but if sleep architecture is broken, the next day's cognitive capacity is already capped. This stack pairs a daytime anxiolytic/nootropic with a night-time sleep-onset peptide.
Typical run length: 4–6 weeks continuous.
Daytime compound — Selank
Selank (NF-012) is a synthetic analog of tuftsin, developed as an anxiolytic without benzodiazepine-class side effects. The published literature associates it with reduced anxiety, improved attention, and upregulation of BDNF without sedation or dependence potential.
Intranasal and subcutaneous dosing are both documented. Subq is the cleaner research route. Daily morning dose.
Night-time compound — DSIP
DSIP (NF-013) — Delta Sleep-Inducing Peptide — is a nine-amino-acid peptide isolated from slow-wave sleep research. It acts on sleep-onset and increases the ratio of delta-wave (slow-wave) sleep to total sleep time.
Inject 15–30 minutes before bed. Effects are subtle at first; most users report clearer benefit in the second week of a protocol as total slow-wave minutes accumulate.
Proposed dosing window
| Compound | Frequency | Published range |
|---|---|---|
| Selank | Daily morning | 250–500 mcg |
| DSIP | Daily pre-bed | 100–300 mcg |
